Literature DB >> 27943349

Problems with continuity of care identified by community pharmacists post-discharge.

H T Ensing1,2,3, E S Koster2, P I van Berkel2, A A van Dooren1, M L Bouvy2.   

Abstract

WHAT IS KNOWN AND
OBJECTIVE: Medication discrepancies are common at hospital discharge, and medication reconciliation is widely endorsed as a preventive strategy. However, implementation is difficult for instance due to the unreliability of patients medication histories. In the Netherlands, community pharmacies are well-informed about their patients' pre-admission medication status which enables thorough post-discharge reconciliation. Our aim was to study the frequency and nature of medication discrepancies, missing patient's knowledge and administrative problems at admission to primary care.
METHODS: A cross-sectional study was conducted in pharmacies belonging to the Utrecht Pharmacy Practice network for Education and Research in the Netherlands. Structured checklists were used to evaluate all discharge prescriptions presented by adult patients discharged from the hospital to their own home during the study period. The primary outcome was all possible problems with continuity of care, defined as (i) the number and type of medication discrepancies, (ii) administrative problems and (iii) the necessity for patient education. RESULTS AND DISCUSSION: In forty-four pharmacies, checklists were completed for 403 patients. Most discharge prescriptions (92%) led to one or more problems with continuity of care (n = 1154, mean 2·9 ± 2·0), divided into medication discrepancies (31%), administrative problems (34%) and necessity for further education (35%). Medication discrepancies (n = 356) resulted mainly from missing pre-admission medication (n = 106) and dose regimen changes (n = 55) on the discharge prescription. Administrative problems (n = 392) originated mainly from administrative incompleteness (n = 177), for example missing reimbursement authorization forms, or supply issues (n = 150), for example insufficient pharmacy stock. The patients' lack of medication knowledge post-discharge was illustrated by the high need for patient education (n = 406). WHAT IS NEW AND
CONCLUSION: Community pharmacists are still confronted with problems due to inadequate documentation at discharge which can inflict harm to patients if not properly addressed. To reduce these problems, a rigorous implementation of the medication reconciliation process at all transition points, standardized electronic transfer of all medication-related information and interdisciplinary collaboration are crucial.
© 2016 The Authors. Journal of Clinical Pharmacy and Therapeutics Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  community pharmacy; continuity of care; hospital discharge; medication discrepancies; medication reconciliation; patient counselling; pharmaceutical care; pharmacy practice; safety

Mesh:

Year:  2016        PMID: 27943349     DOI: 10.1111/jcpt.12488

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN: 0269-4727            Impact factor:   2.512


  15 in total

Review 1.  The scope of drug-related problems in the home care setting.

Authors:  Carla Meyer-Massetti; Christoph R Meier; B Joseph Guglielmo
Journal:  Int J Clin Pharm       Date:  2018-01-11

2.  Medication management surrounding transitions of care: A qualitative assessment of community pharmacists' preferences (MEMO TOC).

Authors:  Miranda Hambrook; Shaylee Peterson; Sean Gorman; Greg Becotte; Andrea Burrows
Journal:  Can Pharm J (Ott)       Date:  2020-08-27

3.  Healthcare professionals' agreement on clinical relevance of drug-related problems among elderly patients.

Authors:  Christine Flagstad Bech; Tine Frederiksen; Christine Tilsted Villesen; Jette Højsted; Per Rotbøll Nielsen; Lene Juel Kjeldsen; Lotte Stig Nørgaard; Lona Louring Christrup
Journal:  Int J Clin Pharm       Date:  2017-12-16

4.  Development of salient medication reminders to facilitate information transfer during transition from inpatient to primary care: the Delphi process.

Authors:  Eliza Lai-Yi Wong; Kam-Shing Tang; Annie Wai-Ling Cheung; Ringo Kin-Cheung Sze; Jack Chi-Him Lau; Francis Chun-Keung Mok; Ping-Wa Yam; Jonathan Yui-Kin Chan; Wai-Cheung Lao; Siu-Ka Mak; Tak-Yeung Chan; Steven Woon-Choy Tsang; Jenny Shun-Wah Lee; Maureen Mo-Lin Wong; Chi-Shing Leung; Kam-Hon Chan; James Ka-Hay Luk; Sze-Yuen Fung; Siu-Fai Lui; Eng-Kiong Yeoh
Journal:  BMJ Open       Date:  2021-05-18       Impact factor: 2.692

5.  e-Interconsultations between a hospital pharmacy service and primary care pharmacy units in Spain.

Authors:  Marta Garcia-Queiruga; Luis Margusino-Framinan; Miguel Gutierrez Estoa; Xose Güeto Rial; Judith Capitán Guarnizo; Isabel Martín-Herranz
Journal:  Eur J Hosp Pharm       Date:  2019-10-31

6.  Hospital discharge: What are the problems, information needs and objectives of community pharmacists? A mixed method approach.

Authors:  Lea D Brühwiler; Kurt E Hersberger; Monika Lutters
Journal:  Pharm Pract (Granada)       Date:  2017-08-25

7.  Does an integrated information technology system provide support for community pharmacists undertaking Discharge Medicines Reviews? An exploratory study.

Authors:  Efthymia Mantzourani; Cheryl M Way; Karen L Hodson
Journal:  Integr Pharm Res Pract       Date:  2017-09-20

8.  Prevalence and Nature of Medication Errors and Medication-Related Harm Following Discharge from Hospital to Community Settings: A Systematic Review.

Authors:  Fatema A Alqenae; Douglas Steinke; Richard N Keers
Journal:  Drug Saf       Date:  2020-06       Impact factor: 5.606

9.  The effect of a pharmacy-led transitional care program on medication-related problems post-discharge: A before-After prospective study.

Authors:  Sara Daliri; Jacqueline G Hugtenburg; Gerben Ter Riet; Bart J F van den Bemt; Bianca M Buurman; Wilma J M Scholte Op Reimer; Marie-Christine van Buul-Gast; Fatma Karapinar-Çarkit
Journal:  PLoS One       Date:  2019-03-12       Impact factor: 3.240

10.  Patient-pharmacist communication during a post-discharge pharmacist home visit.

Authors:  Hendrik T Ensing; Marcia Vervloet; Ad A van Dooren; Marcel L Bouvy; Ellen S Koster
Journal:  Int J Clin Pharm       Date:  2018-05-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.